Jane Street’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.74M | Sell |
19,800
-2,700
| -12% | -$472K | ﹤0.01% | 3967 |
|
|
2025
Q4 | $3.83M | Buy |
22,500
+19,800
| +733% | +$3.04M | ﹤0.01% | 3653 |
|
|
2025
Q3 | $356K | Buy |
2,700
+800
| +42% | +$96K | ﹤0.01% | 8572 |
|
|
2025
Q2 | $202K | Hold |
1,900
| – | – | ﹤0.01% | 8533 |
|
|
2025
Q1 | $236K | Buy |
+1,900
| New | +$248K | ﹤0.01% | 8204 |
|
|
2024
Q3 | – | Sell |
-2,900
| Closed | -$310K | – | 10008 |
|
|
2024
Q2 | $310K | Sell |
2,900
-900
| -24% | -$98.9K | ﹤0.01% | 7749 |
|
|
2024
Q1 | $458K | Buy |
3,800
+1,900
| +100% | +$233K | ﹤0.01% | 6823 |
|
|
2023
Q4 | $234K | Sell |
1,900
-300
| -14% | -$37.4K | ﹤0.01% | 7995 |
|
|
2023
Q3 | $285K | Hold |
2,200
| – | – | ﹤0.01% | 7133 |
|
|
2023
Q2 | $273K | Sell |
2,200
-2,800
| -56% | -$377K | ﹤0.01% | 7271 |
|
|
2023
Q1 | $732K | Buy |
5,000
+900
| +22% | +$133K | ﹤0.01% | 5628 |
|
|
2022
Q4 | $653K | Buy |
4,100
+300
| +8% | +$44K | ﹤0.01% | 5686 |
|
|
2022
Q3 | $507K | Sell |
3,800
-3,300
| -46% | -$502K | ﹤0.01% | 6672 |
|
|
2022
Q2 | $1.11M | Buy |
7,100
+1,600
| +29% | +$246K | ﹤0.01% | 5302 |
|
|
2022
Q1 | $856K | Sell |
5,500
-30,500
| -85% | -$4.43M | ﹤0.01% | 6450 |
|
|
2021
Q4 | $4.59M | Sell |
36,000
-14,900
| -29% | -$1.96M | ﹤0.01% | 2998 |
|
|
2021
Q3 | $6.63M | Sell |
50,900
-15,136
| -23% | -$2.29M | ﹤0.01% | 2341 |
|
|
2021
Q2 | $11.7M | Buy |
66,036
+36,736
| +125% | +$6.36M | ﹤0.01% | 1545 |
|
|
2021
Q1 | $4.82M | Sell |
29,300
-81,300
| -74% | -$13.4M | ﹤0.01% | 2463 |
|
|
2020
Q4 | $18.3M | Buy |
110,600
+47,200
| +74% | +$7.03M | 0.01% | 931 |
|
|
2020
Q3 | $9.04M | Buy |
63,400
+58,600
| +1,221% | +$7.26M | 0.01% | 1292 |
|
|
2020
Q2 | $530K | Buy |
4,800
+2,300
| +92% | +$254K | ﹤0.01% | 5006 |
|
|
2020
Q1 | $249K | Sell |
2,500
-3,400
| -58% | -$440K | ﹤0.01% | 4419 |
|
|
2019
Q4 | $881K | Sell |
5,900
-1,000
| -14% | -$136K | ﹤0.01% | 2938 |
|
|
2019
Q3 | $884K | Buy |
+6,900
| New | +$925K | ﹤0.01% | 2780 |
|
|
2018
Q4 | – | Sell |
-2,100
| Closed | -$353K | – | 5331 |
|
|
2018
Q3 | $353K | Buy |
+2,100
| New | +$361K | ﹤0.01% | 4022 |
|
|
2018
Q2 | – | Sell |
-2,800
| Closed | -$423K | – | 5299 |
|
|
2018
Q1 | $423K | Buy |
+2,800
| New | +$411K | ﹤0.01% | 3651 |
|
|
2017
Q4 | – | Sell |
-6,400
| Closed | -$936K | – | 4902 |
|
|
2017
Q3 | $936K | Buy |
6,400
+2,100
| +49% | +$318K | ﹤0.01% | 2361 |
|
|
2017
Q2 | $669K | Buy |
+4,300
| New | +$658K | ﹤0.01% | 2670 |
|
|
2017
Q1 | – | Sell |
-5,600
| Closed | -$611K | – | 4428 |
|
|
2016
Q4 | $611K | Buy |
5,600
+600
| +12% | +$66.8K | ﹤0.01% | 2632 |
|
|
2016
Q3 | $607K | Buy |
+5,000
| New | +$674K | ﹤0.01% | 2552 |
|
|
2016
Q2 | – | Sell |
-5,000
| Closed | -$653K | – | 4330 |
|
|
2016
Q1 | $653K | Buy |
+5,000
| New | +$622K | ﹤0.01% | 2297 |
|
Other funds holding JAZZ
VPM
VCM
EC
Jane Street's JAZZ Position: Q1 2026 in Review
Jane Street increased its Jazz Pharmaceuticals (JAZZ) stake by 157% in Q1 2026, buying an estimated $23.9M and bringing the position to 223,615 shares worth $42.3M. The position accounts for 0.01% of the portfolio, ranked #1171.
Jane Street first reported a position in JAZZ in Q2 2013 and has held it in 46 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Jane Street held 223,615 shares of Jazz Pharmaceuticals worth $42.3M as of Q1 2026.
- Jane Street bought 136,505 Jazz Pharmaceuticals shares in Q1 2026, an estimated $23.9M.
- Jazz Pharmaceuticals made up 0.01% of Jane Street's portfolio in Q1 2026, its #1171 holding.
- Jane Street first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 46 quarters since.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.